To assess whether S6K1 plays a role downstream of mTOR in mediating mitochondrial disease progression, we crossed whole body and tissue-specific S6K1 knockout mice into the NKO background and examined the impact on health and survival. This evidence concerns the gene RPS6KB1 and inborn mitochondrial metabolism disorder.